Detalles de la búsqueda
1.
Safety, tolerability and pharmacodynamics of apical sodium-dependent bile acid transporter inhibition with volixibat in healthy adults and patients with type 2 diabetes mellitus: a randomised placebo-controlled trial.
BMC Gastroenterol
; 18(1): 3, 2018 Jan 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29304731
2.
Total energy expenditure assessed by salivary doubly labelled water analysis and its relevance for short-term energy balance in humans.
Rapid Commun Mass Spectrom
; 30(1): 143-50, 2016 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26661981
3.
Pharmacodynamics and pharmacokinetics of the novel PAR-1 antagonist vorapaxar (formerly SCH 530348) in healthy subjects.
Eur J Clin Pharmacol
; 68(3): 249-58, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-21935705
4.
Rapid HCV-RNA decline with once daily TMC435: a phase I study in healthy volunteers and hepatitis C patients.
Gastroenterology
; 138(3): 913-21, 2010 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-19852962
5.
Antiviral activity of narlaprevir combined with ritonavir and pegylated interferon in chronic hepatitis C patients.
Hepatology
; 52(5): 1590-9, 2010 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-20938912
6.
A Stepwise Male Introduction Procedure to Prevent Inbreeding in Naturalistic Macaque Breeding Groups.
Animals (Basel)
; 11(2)2021 Feb 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-33669865
7.
Factors determining male introduction success and long-term stability in captive rhesus macaques.
PLoS One
; 14(7): e0219972, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31314795
8.
Evaluation of the safety, tolerability and pharmacokinetics of ALN-RSV01, a novel RNAi antiviral therapeutic directed against respiratory syncytial virus (RSV).
Antiviral Res
; 77(3): 225-31, 2008 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-18242722
9.
Pharmacokinetic and pharmacodynamic assessments of the dipeptidyl peptidase-4 inhibitor PHX1149: double-blind, placebo-controlled, single- and multiple-dose studies in healthy subjects.
Clin Ther
; 29(8): 1692-705, 2007 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-17919550
10.
A low TSH profile predicts olanzapine-induced weight gain and relief by adjunctive topiramate in healthy male volunteers.
Psychoneuroendocrinology
; 66: 101-10, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26802597
11.
Pharmacodynamics, pharmacokinetics, safety, and tolerability of encenicline, a selective α7 nicotinic receptor partial agonist, in single ascending-dose and bioavailability studies.
Clin Ther
; 37(2): 311-24, 2015 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25438724
12.
Long-term safety and efficacy of microRNA-targeted therapy in chronic hepatitis C patients.
Antiviral Res
; 111: 53-9, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25218783
13.
The Value of Desmethylclozapine and Serum CRP in Clozapine Toxicity: A Case Report.
Case Rep Psychiatry
; 2012: 592784, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22934219
14.
Asenapine Safety, Tolerability, and Pharmacokinetics After Single and Multiple Doses in Healthy Volunteers.
Clin Pharmacol Drug Dev
; 1(4): 131-43, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-27121455
15.
Bilateral sensory abnormalities in patients with unilateral neuropathic pain; a quantitative sensory testing (QST) study.
PLoS One
; 7(5): e37524, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22629414
16.
Somatosensory profiles but not numbers of somatosensory abnormalities of neuropathic pain patients correspond with neuropathic pain grading.
PLoS One
; 7(8): e43526, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22927981
17.
Potent immune activation in chronic hepatitis C patients upon administration of an oral inducer of endogenous interferons that acts via Toll-like receptor 7.
Antivir Ther
; 17(4): 657-67, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22301364
18.
Pharmacokinetics and antiviral activity of PHX1766, a novel HCV protease inhibitor, using an accelerated Phase I study design.
Antivir Ther
; 17(2): 365-75, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22293533
19.
Rapid decline of viral RNA in chronic hepatitis C patients treated once daily with IDX320: a novel macrocyclic HCV protease inhibitor.
Antivir Ther
; 17(4): 633-42, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22427481
20.
Safety and antiviral activity of JTK-652: a novel HCV infection inhibitor.
Antivir Ther
; 15(5): 765-73, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20710058